Several possible studies
Story checked
Scientists reveal the hidden danger of missing blood pressure medication | ScienceDaily (opens in a new tab)
sciencedaily.com · 2026-10-25
Short answer
Several possible studiesStudy not confirmed.
Several potential source studies were identified, but no single match could be confirmed. The article's claims remain unverified.
These papers were considered as possible sources, but none could be confirmed as the study behind this story.
Share this check
The story
Scientists reveal the hidden danger of missing blood pressure medication | ScienceDaily
sciencedaily.com · 2026-10-25
The story’s checkable claims.
Read the original story (opens in a new tab)NewsLink checks it
Multiple potential source studies identified.
Several studies match details in the article, but none could be confirmed as its source. The claims have not been assessed against a source study.
View article claimsSearch result
Several studies could fit.
Several studies match details in the article, but none could be confirmed as its source. The claims have not been assessed against a source study.
Evidence layer
Claim by claim
The article's claims are listed below. Without a confirmed source study, they have not been assessed as supported or unsupported.
Reading mode
Scan verdicts. Open evidence only when needed.
Claim 1 of 6Not checkedMissing blood pressure medication could significantly reduce its ability to protect against heart attacks, strokes, and other serious cardiovascular problems, according to findings presented at ESC Congress 2026.View evidenceHide evidence
Not checked
No source study was confirmed for this article. This claim remains unverified, rather than assessed as supported or unsupported.
Claim 2 of 6Not checkedAmong patients with higher adherence, the intervention group had an 11% lower incidence of major cardiovascular events compared with the comparator group, whereas lower adherence was associated with no statistically significant reduction in events.View evidenceHide evidence
As stated11% lower incidence
Not checked
No source study was confirmed for this article. This claim remains unverified, rather than assessed as supported or unsupported.
Claim 3 of 6Not checkedResearchers analyzed individual patient data from 91,339 participants across nine clinical trials to assess the impact of adherence to antihypertensive treatment.View evidenceHide evidence
As stated91,339 participants across nine clinical trials
Not checked
No source study was confirmed for this article. This claim remains unverified, rather than assessed as supported or unsupported.
Claim 4 of 6Not checkedParticipants who took at least 80% of their assigned medication were considered higher adherence, while those taking less than 80% were considered lower adherence.View evidenceHide evidence
As stated80% adherence threshold
Not checked
No source study was confirmed for this article. This claim remains unverified, rather than assessed as supported or unsupported.
Claim 5 of 6Not checkedAmong higher-adherence participants, systolic blood pressure was 5.2 mmHg lower in the intervention group than in the comparator group, versus 3.0 mmHg lower among lower-adherence participants.View evidenceHide evidence
As stated5.2 mmHg vs 3.0 mmHg
Not checked
No source study was confirmed for this article. This claim remains unverified, rather than assessed as supported or unsupported.
Claim 6 of 6Not checkedThe researchers argued that routine assessment of medication adherence, better patient education, and strategies such as simplifying schedules, combining pills, or using longer-acting drugs could help patients avoid losing benefit from treatment.View evidenceHide evidence
Not checked
No source study was confirmed for this article. This claim remains unverified, rather than assessed as supported or unsupported.
Method layer
Study not confirmed.
The search results are available for you to inspect. Without a confirmed source study, they cannot establish whether the story’s claims are supported or contradicted.
Search results
Candidate papers, not confirmed sources.
PubMed, Crossref, Europe PMC · 15 candidate papers
Availability and reimbursement of fixed-dose combination medicines for hypertension treatment in Central and Eastern Europe.
Frontiers in Pharmacology · 2026 · PubMed
Ethical Aspects of Measuring Adherence to Antihypertensive Treatment
Updates in Hypertension and Cardiovascular Protection · 2018 · Crossref
Psychosocial Factors, Self-Care and Medication Adherence among Individuals Living with Hypertension in Greece: A Study Protocol
Europe PMC
Beyond Conventional Antihypertensives: RNA Interference, Endothelin Antagonism, and Aldosterone-Synthase Inhibition in the Current Therapeutic Landscape.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions · 2026 · PubMed
The Impact of Antihypertensive Drugs on Adherence
Updates in Hypertension and Cardiovascular Protection · 2018 · Crossref